DE10399005I2 - Optisches Isomeres eines Imidazolderivats. - Google Patents

Optisches Isomeres eines Imidazolderivats.

Info

Publication number
DE10399005I2
DE10399005I2 DE2003199005 DE10399005C DE10399005I2 DE 10399005 I2 DE10399005 I2 DE 10399005I2 DE 2003199005 DE2003199005 DE 2003199005 DE 10399005 C DE10399005 C DE 10399005C DE 10399005 I2 DE10399005 I2 DE 10399005I2
Authority
DE
Germany
Prior art keywords
optical isomer
imidazole derivative
imidazole
derivative
medetomidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE2003199005
Other languages
German (de)
English (en)
Other versions
DE10399005I1 (de
Inventor
Arto Johannes Karjalainen
Raimo Einari Virtanen
Eino Juhani Savolainen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orion Oyj
Original Assignee
Orion Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10620775&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE10399005(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Orion Oyj filed Critical Orion Oyj
Publication of DE10399005I1 publication Critical patent/DE10399005I1/de
Application granted granted Critical
Publication of DE10399005I2 publication Critical patent/DE10399005I2/de
Active legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/58Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Optical Record Carriers And Manufacture Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE2003199005 1987-07-16 1988-07-08 Optisches Isomeres eines Imidazolderivats. Active DE10399005I2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8716803A GB2206880B (en) 1987-07-16 1987-07-16 Optical isomers of an imidazole derivative

Publications (2)

Publication Number Publication Date
DE10399005I1 DE10399005I1 (de) 2003-06-05
DE10399005I2 true DE10399005I2 (de) 2012-06-06

Family

ID=10620775

Family Applications (2)

Application Number Title Priority Date Filing Date
DE2003199005 Active DE10399005I2 (de) 1987-07-16 1988-07-08 Optisches Isomeres eines Imidazolderivats.
DE8888306250T Expired - Lifetime DE3867945D1 (de) 1987-07-16 1988-07-08 Optisches isomeres eines imidazolderivats.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE8888306250T Expired - Lifetime DE3867945D1 (de) 1987-07-16 1988-07-08 Optisches isomeres eines imidazolderivats.

Country Status (29)

Country Link
US (1) US4910214A (cg-RX-API-DMAC7.html)
EP (1) EP0300652B1 (cg-RX-API-DMAC7.html)
JP (1) JPH0625138B2 (cg-RX-API-DMAC7.html)
KR (1) KR940007311B1 (cg-RX-API-DMAC7.html)
CN (1) CN1022323C (cg-RX-API-DMAC7.html)
AT (1) ATE71941T1 (cg-RX-API-DMAC7.html)
AU (1) AU600839B2 (cg-RX-API-DMAC7.html)
BG (1) BG60473B2 (cg-RX-API-DMAC7.html)
CA (1) CA1337659C (cg-RX-API-DMAC7.html)
CY (2) CY1787A (cg-RX-API-DMAC7.html)
DD (1) DD281807A5 (cg-RX-API-DMAC7.html)
DE (2) DE10399005I2 (cg-RX-API-DMAC7.html)
DK (1) DK165788C (cg-RX-API-DMAC7.html)
ES (1) ES2038757T3 (cg-RX-API-DMAC7.html)
FI (1) FI95375C (cg-RX-API-DMAC7.html)
GB (1) GB2206880B (cg-RX-API-DMAC7.html)
GR (1) GR3003878T3 (cg-RX-API-DMAC7.html)
HK (1) HK56094A (cg-RX-API-DMAC7.html)
HU (1) HU198693B (cg-RX-API-DMAC7.html)
IE (1) IE60456B1 (cg-RX-API-DMAC7.html)
IL (1) IL87076A0 (cg-RX-API-DMAC7.html)
LU (1) LU91010I2 (cg-RX-API-DMAC7.html)
NL (1) NL300117I2 (cg-RX-API-DMAC7.html)
NO (2) NO170579C (cg-RX-API-DMAC7.html)
NZ (1) NZ225362A (cg-RX-API-DMAC7.html)
PT (1) PT88013B (cg-RX-API-DMAC7.html)
SU (1) SU1648248A3 (cg-RX-API-DMAC7.html)
UA (1) UA5560A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA885134B (cg-RX-API-DMAC7.html)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2215206B (en) * 1988-02-29 1991-07-03 Farmos Oy 4-substituted imidazole derivatives useful in perioperative care
US5124157A (en) * 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
US5120713A (en) * 1990-09-10 1992-06-09 Applied Research Systems Ars Holding N.V. Treatment of obesity with an alpha-2-adrenergic agonist and a growth hormone releasing peptide
GB9111732D0 (en) * 1991-05-31 1991-07-24 Orion Yhtymae Oy The use of certain salts of medetomidine and its optically active enantiomers to regulate the rate of transdermal administration of the drugs
GB2281206A (en) * 1993-08-25 1995-03-01 Orion Yhtymae Oy Use of dexmedetomidine
GB9425211D0 (en) * 1994-12-14 1995-02-15 Ucb Sa Substituted 1H-imidazoles
IN187238B (cg-RX-API-DMAC7.html) * 1995-06-30 2002-03-09 Astra Ab
GB9521680D0 (en) * 1995-10-23 1996-01-03 Orion Yhtymo Oy New use of imidazole derivatives
US5866579A (en) 1997-04-11 1999-02-02 Synaptic Pharmaceutical Corporation Imidazole and imidazoline derivatives and uses thereof
AR015744A1 (es) * 1998-04-01 2001-05-16 Orion Corp Uso de dexmedetomidina para sedacion en terapia intensiva
US6716867B1 (en) 1998-04-01 2004-04-06 Orion Corporation Use of dexmedetomidine for ICU sedation
NZ518447A (en) 1999-10-29 2004-10-29 Orion Corp Treatment or prevention of hypotension and shock
US6388090B2 (en) * 2000-01-14 2002-05-14 Orion Corporation Imidazole derivatives
US7141597B2 (en) * 2003-09-12 2006-11-28 Allergan, Inc. Nonsedating α-2 agonists
TWI435729B (zh) 2005-11-09 2014-05-01 Combinatorx Inc 治療病症之方法,組合物及套組
ES2396039T3 (es) 2006-03-16 2013-02-18 Tris Pharma, Inc. Formulaciones de liberación modificada que contienen complejos de fármaco-resina de intercambio iónico
US7795263B2 (en) * 2008-07-08 2010-09-14 Wildlife Laboratories, Inc. Pharmaceutical combination for and method of anesthetizing and immobilizing non-domesticated mammals
EP2370136A4 (en) * 2008-12-01 2015-12-30 Map Pharmaceuticals Inc INHALATIVE RELEASE PROCEDURES AND DEVICES
US8555875B2 (en) 2008-12-23 2013-10-15 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
US20110021588A1 (en) * 2009-05-15 2011-01-27 Recro Pharma, Inc. Sublingual dexmeditomidine compositions and methods of use thereof
CN101671305A (zh) * 2009-09-29 2010-03-17 北京华禧联合科技发展有限公司 一种拆分美托咪定的左旋及右旋对映体的方法
CN102464619A (zh) * 2010-11-17 2012-05-23 桑迪亚医药技术(上海)有限责任公司 一种左旋4-[1-(2,3-二甲基苯基)乙基]-1r-咪唑消旋化方法
US20130096170A1 (en) 2011-10-14 2013-04-18 Hospira, Inc. Methods of treating pediatric patients using dexmedetomidine
WO2013069025A1 (en) 2011-11-11 2013-05-16 Neon Laboratories Ltd. "process for the preparation of dexmedetomidine"
SG10201604653TA (en) 2011-12-11 2016-07-28 Recro Pharma Inc Intranasal dexmedetomidine compositions and methods of use thereof
US8242158B1 (en) 2012-01-04 2012-08-14 Hospira, Inc. Dexmedetomidine premix formulation
ITMI20120311A1 (it) * 2012-02-29 2013-08-30 Edmond Pharma Srl Procedimento per la risoluzione di medetomidina e recupero dell'enantiomero indesiderato
WO2014028610A1 (en) 2012-08-15 2014-02-20 Tris Pharma, Inc. Methylphenidate extended release chewable tablet
KR102146690B1 (ko) 2012-10-15 2020-08-24 오리온 코포레이션 수의학적 소음 혐오증 완화 방법
EP3054935B1 (en) 2013-10-07 2020-12-09 Teikoku Pharma USA, Inc. Methods and compositions for treating attention deficit hyperactivity disorder, anxiety and insomnia using dexmedetomidine transdermal compositions
ES2847936T3 (es) 2013-10-07 2021-08-04 Teikoku Pharma Usa Inc Métodos y composiciones para el suministro transdérmico de una cantidad no sedante de dexmedetomidina
TWI704933B (zh) 2013-10-07 2020-09-21 美商帝國製藥美國股份有限公司 右美托咪啶經皮輸送裝置及使用其之方法
CN105175339B (zh) * 2015-10-09 2018-01-16 辰欣药业股份有限公司 一种制备盐酸右美托咪定的方法
US9717796B1 (en) 2016-04-20 2017-08-01 Slypharma, Llc Heat sterilizeable, premixed, ready to use dexmedetomidine solution packaged in a flexible plastic container
FR3054218B1 (fr) * 2016-07-22 2020-03-06 Universite De Rouen Procede de dedoublement de sels de baclofene
US11160791B2 (en) 2018-11-01 2021-11-02 Medefil, Inc. Dexmedetomidine injection premix formulation in ready to use (RTU) bags
CN115197149B (zh) * 2021-04-02 2023-09-22 四川大学华西医院 一种5-苄基咪唑类化合物及其制备方法和用途
CN114671811A (zh) * 2022-04-14 2022-06-28 南京正科医药股份有限公司 一种右美托咪定拆分副产物的外消旋化回收方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU518569B2 (en) * 1979-08-07 1981-10-08 Farmos-Yhtyma Oy 4-benzyl- and 4-benzoyl imidazole derivatives
GB2092569B (en) * 1981-02-05 1984-09-19 Farmos Oy Substituted imidazole derivatives and their preparation and use
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
FI844786A0 (fi) 1984-12-04 1984-12-04 Farmos Oy Terapeutiskt utnyttjbar foerening.
DE3531682A1 (de) * 1985-09-05 1987-03-12 Thomae Gmbh Dr K (+)-6-chlor-5,10-dihydro-5-((1-methyl-4- piperidinyl)acetyl)-11h-dibenzo(b,e)(1,4) diazepin-11-on, seine isolierung und verwendung als arzneimittel

Also Published As

Publication number Publication date
DE10399005I1 (de) 2003-06-05
DK165788C (da) 1993-06-14
ATE71941T1 (de) 1992-02-15
FI95375B (fi) 1995-10-13
NO883155L (no) 1989-01-17
LU91010I2 (fr) 2003-06-19
NL300117I1 (nl) 2003-05-01
CN1030576A (zh) 1989-01-25
ES2038757T3 (es) 1993-08-01
PT88013A (pt) 1989-06-30
NO170579B (no) 1992-07-27
AU1894188A (en) 1989-01-19
JPS6434968A (en) 1989-02-06
IE60456B1 (en) 1994-07-13
FI882819A0 (fi) 1988-06-14
DE3867945D1 (de) 1992-03-05
DK165788B (da) 1993-01-18
GB2206880A (en) 1989-01-18
ZA885134B (en) 1989-04-26
NL300117I2 (nl) 2003-10-01
DK386288D0 (da) 1988-07-11
FI95375C (fi) 1996-01-25
UA5560A1 (uk) 1994-12-28
CY1787A (en) 1995-10-20
IE882174L (en) 1989-01-16
GB2206880B (en) 1991-04-24
CY2004006I1 (el) 2009-11-04
CA1337659C (en) 1995-11-28
GB8716803D0 (en) 1987-08-19
HUT48218A (en) 1989-05-29
FI882819L (fi) 1989-01-17
NO170579C (no) 1992-11-04
SU1648248A3 (ru) 1991-05-07
KR890002030A (ko) 1989-04-07
GR3003878T3 (cg-RX-API-DMAC7.html) 1993-03-16
NZ225362A (en) 1990-07-26
NO883155D0 (no) 1988-07-15
CN1022323C (zh) 1993-10-06
NO2003004I2 (no) 2005-03-21
CY2004006I2 (el) 2009-11-04
JPH0625138B2 (ja) 1994-04-06
KR940007311B1 (ko) 1994-08-12
DK386288A (da) 1989-01-17
PT88013B (pt) 1995-03-01
BG60473B2 (bg) 1995-04-28
HK56094A (en) 1994-06-03
US4910214A (en) 1990-03-20
IL87076A0 (en) 1988-12-30
EP0300652B1 (en) 1992-01-22
DD281807A5 (de) 1990-08-22
EP0300652A1 (en) 1989-01-25
HU198693B (en) 1989-11-28
AU600839B2 (en) 1990-08-23

Similar Documents

Publication Publication Date Title
DE10399005I1 (de) Optisches Isomeres eines Imidazolderivats
KR850002754A (ko) 삼-치환 옥사졸 유도체의 제조방법
DE3883851D1 (de) Beschichtung für optisches Fiberband.
LV10452A (lv) (1H-Azol-1-ilmetil)-aizvietotu benzotriazolu atvasinajumu iegusanas metode
PL144899B1 (en) Method of obtaining novel triazine derivatives
BG36932A3 (bg) Метод за получаване на 1-(3-хидрокси-4-метаксибензоил)-3- хидрокси-2-пиролидинон
BG40148A3 (bg) Метод за получаване на хетероциклично съединение
DE3873562D1 (de) Beta-alkylmelatonine.
FI905127A7 (fi) Menetelmä substituoidun tai substituoimattoman 4(5)-(omega-aminoalkyyl i)imidatsolin valmistamiseksi
IT1190526B (it) Apparecchio perfezionato per la sfogliatura di piccoli tronchi d'albero per la produzione di impiallacciatura
DE3268403D1 (de) Decarboxylase-inhibiting fluorinated alkane diamine derivatives
AU572515B2 (en) Lowering the cloud point of hydrodewaxed base stocks
ES2078434T3 (es) Hexahidrobenz(cd)indoles y procedimiento para su preparacion.
FI823563A0 (fi) Foerfarande foer framstaellning av 1-(2,4-diklorfenoxi)-3-(3,4-dimetoxi- -fenetylamino)-propanol-(2)
BG40812A3 (en) Method for preparing derivatives of pyroxycam
KR900009634A (ko) 이미다졸 유도체의 제조방법
IT8023833A0 (it) Griffa per la sospensione di linee aeree per filovie.
FI804056A7 (fi) Menetelmä imidatsolijohdannaisen valmistamiseksi.
IT1213810B (it) Congegno ottico-meccanico per la determinazione dell'asse ottico
EP0274567A3 (en) Servo-system for the positioning of an optical head